Cargando…
[(18)F]-Fludarabine for Hematological Malignancies
With the emergence of PET/CT using (18)F-FDG, molecular imaging has become the reference for lymphoma lesion detection, tumor staging, and response assessment. According to the response in some lymphoma subtypes it has also been utilized for prognostication of disease. Although (18)F-FDG has proved...
Autores principales: | Barré, Louisa, Hovhannisyan, Narinée, Bodet-Milin, Caroline, Kraeber-Bodéré, Françoise, Damaj, Gandhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478790/ https://www.ncbi.nlm.nih.gov/pubmed/31058154 http://dx.doi.org/10.3389/fmed.2019.00077 |
Ejemplares similares
-
[(18)F]Fludarabine-PET in a murine model of multiple myeloma
por: Hovhannisyan, Narinée, et al.
Publicado: (2017) -
Evaluation of the specificity of [(18)F]fludarabine PET/CT in a xenograft model of follicular lymphoma: comparison with [(18)F]FDG and impact of rituximab therapy
por: Hovhannisyan, Narinée, et al.
Publicado: (2015) -
[(18)F]Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [(18)F]FDG in human xenograft models
por: Hovhannisyan, Narinée, et al.
Publicado: (2018) -
Prognostic Value and Clinical Impact of (18)FDG-PET in the Management of Children with Burkitt Lymphoma after Induction Chemotherapy
por: Bailly, Clément, et al.
Publicado: (2014) -
Incidental findings suggestive of COVID-19 in asymptomatic cancer patients undergoing 18F-FDG PET/CT in a low prevalence region
por: Pallardy, Amandine, et al.
Publicado: (2020)